ARCT
Conviction 80HealthcareScan · Thu, Sep 24, 2026Arcturus Therapeutics Holdings Inc. (ARCT) closed at $14.14 (+6.32%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 52, RS Rating 97, -39.0% from its 52-week high, +126.2% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- ARCT Looks 565.3% Overvalued on GF Value™GuruFocus · Thu, Sep 24, 2026
- Arcturus stock upgraded to Buy at Citi (ARCT:NASDAQ)Seeking Alpha · Thu, Sep 24, 2026
- ARCT Maintained by BTIG -- Price Target Lowered to $20GuruFocus · Thu, Sep 24, 2026
- Arcturus Therapeutics Holdings Inc. (ARCT) Discusses Phase II Data for OTC Deficiency and Advances in mRNA Liver Therapeutics Platform - Slideshow (NASDAQ:ARCT) 2026-09-24Seeking Alpha · Thu, Sep 24, 2026
- ARCT Looks 521.5% Overvalued on GF Value™GuruFocus · Wed, Sep 23, 2026
- Arcturus stock ticks up on Phase 2 data, new mRNA platformInvesting.com Nigeria · Wed, Sep 23, 2026
- Arcturus Showcases Phase 2 ARCT-810 Data, mRNA AdvancesTipRanks · Wed, Sep 23, 2026
- Arcturus Therapeutics Holdings Inc to Host Virtual Presentation TranscriptGuruFocus · Wed, Sep 23, 2026
- Arcturus Therapeutics Announces Interim OTC Deficiency Phase 2 Results and Introduces LUNAR 2.0™ Next-Generation mRNA Delivery PlatformYahoo Finance · Wed, Sep 23, 2026
- Arcturus Therapeutics Holdings Inc.: 8-K filedSEC EDGAR · Wed, Sep 23, 2026
Congress activity
Disclosed STOCK Act trades in ARCT
Insider activity
SEC Form 4 transactions in ARCT
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
MULROY DENNIS Chief Financial Officer · Employee Stock Option (right to buy) · 2026-05-01 | Grant | 100K | $0 | 2026-05-01 | 2026-05-07 |
SEC filings
EDGAR filings in ARCT · 6 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.